Benzinga | Nov 3, 2020 08:05AM EST

Alkermes Pharma Ireland Limited Granted Patent by USPTO Number 10,822,306 Dated November 3, 2020 Titled 'Heterocyclic compounds for the treatment of neurological and psychological disorders'

Alkermes Pharma Ireland Limited Granted Patent by USPTO Number 10,822,306 Dated November 3, 2020 Titled 'Heterocyclic compounds for the treatment of neurological and psychological disorders'